Holen Sie sich die Stockscreener-App
1.81
2.69%
-0.05
Schlusskurs vom Vortag:
$1.86
Offen:
$1.84
24-Stunden-Volumen:
38,748
Relative Volume:
0.46
Marktkapitalisierung:
$5.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-0.2614
EPS:
-6.9236
Netto-Cashflow:
$-10.11M
1W Leistung:
-12.14%
1M Leistung:
-46.76%
6M Leistung:
-18.83%
1J Leistung:
-29.02%
1-Tages-Spanne:
$1.775
$1.9186
1-Wochen-Bereich:
$1.775
$2.21
52-Wochen-Spanne:
$1.72
$4.10
Gt Biopharma Inc Stock (GTBP) Company Profile
Firmenname
Gt Biopharma Inc
Sektor
Branche
Telefon
(800) 304-9888
Adresse
505 MONTGOMERY STREET, SAN FRANCISCO
Vergleichen Sie GTBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.65 | 833.82M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.31 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.82 | 120.57M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.152 | 320.01M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.63 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | ROTH MKM | Buy |
| 2021-05-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-13 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-17 | Eingeleitet | ROTH Capital | Buy |
Gt Biopharma Inc Aktie (GTBP) Neueste Nachrichten
What makes GT Biopharma Inc. stock attractive to long term investorsFree Fundamental Winners With Safe Entry Plan - Newser
What makes GT Biopharma Inc. stock price move sharplyUnlock powerful market trend analysis - jammulinksnews.com
Is GT Biopharma Inc. stock entering bullish territoryDownside Risk Evaluation and Stock Analysis - Newser
What is GT Biopharma Inc. company’s growth strategyTurbocharged investment results - jammulinksnews.com
What drives GT Biopharma Inc. stock priceTriple-digit return opportunities - jammulinksnews.com
Is it time to cut losses on GT Biopharma Inc.Short Squeeze Opportunities with Indicators - Newser
Is GT Biopharma Inc. stock overvalued or undervaluedCapitalize on market trends with expert guidance - jammulinksnews.com
Is it the right time to buy GT Biopharma Inc. stockUnlock high-yield investment opportunities - jammulinksnews.com
What is the dividend policy of GT Biopharma Inc. stockAchieve rapid returns with smart investment plans - jammulinksnews.com
How volatile is GT Biopharma Inc. stock compared to the marketCapitalize on high-yield stock opportunities - jammulinksnews.com
Analyzing GT Biopharma Inc. with multi timeframe chartsFree Buy Signal Based on Chart Analysis - Newser
Trendline Breach Raises Concern for GT Biopharma Inc. InvestorsBreakout Momentum Picks With Protection Outlined - beatles.ru
Why GT Biopharma Inc. stock attracts strong analyst attentionRapid Trade Forecast Based on Indicators - Newser
Is GT Biopharma Inc. stock reversal real or fakeForecast Model for Intraday Buy Signals - Newser
What are the technical indicators suggesting about GT Biopharma Inc.Post Market Review For 2025 - jammulinksnews.com
What institutional investors are buying GT Biopharma Inc. stockTop Growth Tips For Consistent Profits - jammulinksnews.com
What data driven models say about GT Biopharma Inc.’s futureAI Risk Optimized Trade Forecast Planner - Newser
Best data tools to analyze GT Biopharma Inc. stockValue Holding Return Summary With Outlook - Newser
How GT Biopharma Inc. stock performs during market volatilityFree AI Forecast for Trending Stocks - Newser
Should I hold or sell GT Biopharma Inc. stock in 2025Daily Trading Guidance To Watch Now - jammulinksnews.com
Top chart patterns to watch in GT Biopharma Inc.Predictive System for Long-Term Stock Forecast - Newser
Published on: 2025-07-30 05:17:05 - Newser
Full technical analysis of GT Biopharma Inc. stockSector-Wise Equity Performance Trend Forecast - Newser
Has GT Biopharma Inc. Stock Ever Crashed Historical Volatility ReviewSmart Chart Forecasting with AI Algorithms - Newser
Does GT Biopharma Inc. stock perform well during market downturnsBuild wealth with high-performing stocks - jammulinksnews.com
What markets is EXLS expanding into Is GT Biopharma Inc. stock a good long term investment optionCapitalize on fast-moving stock opportunities - jammulinksnews.com
What are analysts’ price targets for GT Biopharma Inc. in the next 12 monthsTrack high-yield stocks before they peak - jammulinksnews.com
Will GT Biopharma Inc. Stock Benefit from AI and Green Energy TrendsPrecision Entry Strategy - metal.it
Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):